Jon W. Chesebrough
Impact in
- Oncology top 10%
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
-
- Immunotherapy and Immune Responses
Papers in
- Oncology 4
- CAR-T cell therapy research 2
- Cancer Immunotherapy and Biomarkers 2
- Peptidase Inhibition and Analysis 1
- Co-authors
- Robert E. Hollingsworth (2 shared papers)Leslie K. Wetzel (2 shared papers)Jonathan Rios‐Doria (2 shared papers)Raymond P. Rothstein (2 shared papers)Ching Ching Leow (2 shared papers)Nicholas M. Durham (1 shared paper)Nicholas Holoweckyj (1 shared paper)Wei Zhao (1 shared paper)
- Journals
- Molecular Cancer Therapeutics (3 papers)Cancer Research (2 papers)Cytotherapy (1 paper)Journal of Biological Chemistry (1 paper)Neoplasia (1 paper)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Jon W. Chesebrough
8 papers receiving 513 citations
Peers
Comparison fields: 5 of 56
- Oncology 248
- Immunology 123
- Endocrinology, Diabetes and Metabolism 75
- Radiology, Nuclear Medicine and Imaging 95
- Cancer Research 51
Countries citing papers authored by Jon W. Chesebrough
This map shows the geographic impact of Jon W. Chesebrough's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon W. Chesebrough with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon W. Chesebrough more than expected).
Fields of papers citing papers by Jon W. Chesebrough
This network shows the impact of papers produced by Jon W. Chesebrough. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon W. Chesebrough. The network helps show where Jon W. Chesebrough may publish in the future.
Co-authors
The 25 scholars most cited alongside Jon W. Chesebrough, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 158 | |
| 2 | 2017 | 120 | |
| 3 | 2011 | 109 | |
| 4 | 2015 | 49 | |
| 5 | 2001 | 39 | |
| 6 | 2009 | 34 | |
| 7 | 2013 | 21 | |
| 8 | 2022 | 10 |
About Jon W. Chesebrough
Jon W. Chesebrough is a scholar working on Oncology, Toxicology, Immunology, Molecular Biology and Cancer Research, having authored 8 papers that have together received 540 indexed citations. Recurring topics across this work include CAR-T cell therapy research (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Peptidase Inhibition and Analysis (1 paper), Heat shock proteins research (1 paper), Tumors and Oncological Cases (1 paper), Cancer, Stress, Anesthesia, and Immune Response (1 paper), Toxin Mechanisms and Immunotoxins (1 paper) and Growth Hormone and Insulin-like Growth Factors (1 paper). The work is most often cited by research in Oncology (248 citations), Immunology (123 citations), Endocrinology, Diabetes and Metabolism (75 citations), Radiology, Nuclear Medicine and Imaging (95 citations) and Cancer Research (51 citations). Jon W. Chesebrough has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Robert E. Hollingsworth, Leslie K. Wetzel, Jonathan Rios‐Doria, Raymond P. Rothstein, Ching Ching Leow, Nicholas M. Durham, Nicholas Holoweckyj, Wei Zhao, Bahija Jallal and Yong Seok Chang. Their work appears in journals such as Molecular Cancer Therapeutics, Cancer Research, Cytotherapy, Journal of Biological Chemistry and Neoplasia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.